000 01250 a2200325 4500
005 20250516104411.0
264 0 _c20121220
008 201212s 0 0 eng d
022 _a1179-1950
024 7 _a10.2165/11635690-000000000-00000
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMurukesan, Vidhya
245 0 0 _aManaging post-transplant lymphoproliferative disorders in solid-organ transplant recipients: a review of immunosuppressant regimens.
_h[electronic resource]
260 _bDrugs
_cAug 2012
300 _a1631-43 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aClinical Trials, Phase II as Topic
650 0 4 _aClinical Trials, Phase III as Topic
650 0 4 _aDrug Evaluation, Preclinical
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aLymphoproliferative Disorders
_xdrug therapy
650 0 4 _aProspective Studies
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aRisk Factors
650 0 4 _aTransplants
_xadverse effects
700 1 _aMukherjee, Sandeep
773 0 _tDrugs
_gvol. 72
_gno. 12
_gp. 1631-43
856 4 0 _uhttps://doi.org/10.2165/11635690-000000000-00000
_zAvailable from publisher's website
999 _c22002706
_d22002706